The Pharma Data

SEPTEMBER 1, 2020

Gaining insight into long-term therapeutic outcomes can enable clinicians to identify the most appropriate treatment approach for their multiple sclerosis patients. The most common TEAEs were nasopharyngitis (17.9%), headache (14%), upper respiratory tract infection (9.9%) and lymphopenia (9.6%). Most common Adverse Reactions (?

Trials 52

Trials Clinical Trials Clinical Trials Vaccination 52

pharmaphorum

MARCH 15, 2022

Smaller societies such as the European Respiratory Society (ERS) reported a 50% increase : 33,784 virtual cf 22,094 physical. Results from a 2021 survey of preferences from over 300 doctors in 6 countries (EU & USA) across 14 therapeutic areas . One important caveat here is that delegate registration fees were waived.

Doctors 103

Doctors Doctor Cardiology Allergies 103

XTalks

AUGUST 2, 2023

In this in-depth article, we embark on a captivating journey to uncover the top 30 pharma and biotech companies that have been instrumental in shaping the future of medicine. For example, Ocrevus will be challenged by Novartis’ Kesimpta (ofatumumab) and TG Therapeutics’ Briumvi (ublituximab). But all three drugs have new competitors.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

APRIL 28, 2021

This new therapeutic regimen has the potential to become a standard of care for patients with relapsed multiple myeloma , who now have another treatment option earlier in the progression of their disease.”. Department of Hematology, University Hospital of Nantes, France. The most frequent adverse reactions (?20%) of patients receiving Kd.

Clinical Trials 40

Clinical Trials Clinical Trials Production Trials 40

The Pharma Data

SEPTEMBER 15, 2020

Company has 89 pipeline projects spread across 6 targeted therapeutic areas with 4 programs in registration and 23 in Phase 3. The company announced the initiation of its Phase 1b clinical trial to evaluate the safety of a novel investigational therapeutic for COVID-19, PF-07304814. THERAPEUTIC AREAS OF FOCUS. for RSV A and 18.0

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

The Pharma Data

JUNE 18, 2021

The depth of response achieved with this regimen is reflected in the 30-month progression-free survival (PFS) rate of ~95% across all treated patients, including the subset receiving placebo after the fixed-duration treatment.

Medicine 40

Medicine Production FDA Approval Trials 40

The Pharma Data

MAY 13, 2021

Therefore I headed back to school to get my Masters Degree in Exercise Science with a focus on corrective exercise and therapeutic exercise. Rick recently completed his Masters of Science degree focusing on corrective exercise and therapeutic exercises for the rotator cuff. Respiratory Therapist and Personal trainer/Fitness leader.

Production 52

Production Medicine Vaccination Vaccine 52